LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy
| dc.contributor.author | Schwab, Karima | |
| dc.contributor.author | Frahm, Silke | |
| dc.contributor.author | Magbagbeolu, Mandy | |
| dc.contributor.author | Horsley, David | |
| dc.contributor.author | Goatman, Elizabeth | |
| dc.contributor.author | Melis, Valeria | |
| dc.contributor.author | Theuring, Franz | |
| dc.contributor.author | Ishaq, Ahtsham | |
| dc.contributor.author | Storey, John M. D. | |
| dc.contributor.author | Harrington, Charles | |
| dc.contributor.author | Wischik, Claude | |
| dc.contributor.author | Riedel, Gernot | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Chemistry | en |
| dc.contributor.institution | University of Aberdeen.Neuroscience | en |
| dc.date.accessioned | 2024-07-16T09:39:00Z | |
| dc.date.available | 2024-07-16T09:39:00Z | |
| dc.date.issued | 2024-05-05 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 50 | |
| dc.format.extent | 13822580 | |
| dc.identifier | 284936140 | |
| dc.identifier | e5b2c94a-a6e0-4dc7-918d-6f94133b9409 | |
| dc.identifier | 38503400 | |
| dc.identifier | 85188729513 | |
| dc.identifier.citation | Schwab, K, Frahm, S, Magbagbeolu, M, Horsley, D, Goatman, E, Melis, V, Theuring, F, Ishaq, A, Storey, J M D, Harrington, C, Wischik, C & Riedel, G 2024, 'LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy', European Journal of Pharmacology, vol. 970, 176505. https://doi.org/10.1016/j.ejphar.2024.176505 | en |
| dc.identifier.doi | 10.1016/j.ejphar.2024.176505 | |
| dc.identifier.issn | 0014-2999 | |
| dc.identifier.other | ORCID: /0000-0001-7063-7136/work/156220008 | |
| dc.identifier.other | ORCID: /0000-0002-5261-5467/work/156220214 | |
| dc.identifier.other | ORCID: /0000-0003-2250-3920/work/173415861 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23810 | |
| dc.identifier.vol | 970 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | European Journal of Pharmacology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Alpha-synuclein | en |
| dc.subject | Aggregation inhibitor | en |
| dc.subject | Parkinson's disease | en |
| dc.subject | Mouse model | en |
| dc.subject | RM Therapeutics. Pharmacology | en |
| dc.subject | RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry | en |
| dc.subject | Supplementary Data | en |
| dc.subject | DAS | en |
| dc.subject.lcc | RM | en |
| dc.subject.lcc | RC0321 | en |
| dc.title | LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Schwab_etal_EJP_LETC_inhibits_-Syn_VOR.pdf
- Size:
- 13.18 MB
- Format:
- Adobe Portable Document Format
